Dysregulation of Glucagon Secretion by Hyperglycemia-Induced Sodium-Dependent Reduction of ATP Production
Jakob G Knudsen, Alexander Hamilton, Reshma Ramracheya, Andrei I Tarasov, Melissa Brereton, Elizabeth Haythorne, Margarita V Chibalina, Peter Spégel, Hindrik Mulder, Quan Zhang, Frances M Ashcroft, Julie Adam, Patrik Rorsman, Jakob G Knudsen, Alexander Hamilton, Reshma Ramracheya, Andrei I Tarasov, Melissa Brereton, Elizabeth Haythorne, Margarita V Chibalina, Peter Spégel, Hindrik Mulder, Quan Zhang, Frances M Ashcroft, Julie Adam, Patrik Rorsman
Abstract
Diabetes is a bihormonal disorder resulting from combined insulin and glucagon secretion defects. Mice lacking fumarase (Fh1) in their β cells (Fh1βKO mice) develop progressive hyperglycemia and dysregulated glucagon secretion similar to that seen in diabetic patients (too much at high glucose and too little at low glucose). The glucagon secretion defects are corrected by low concentrations of tolbutamide and prevented by the sodium-glucose transport (SGLT) inhibitor phlorizin. These data link hyperglycemia, intracellular Na+ accumulation, and acidification to impaired mitochondrial metabolism, reduced ATP production, and dysregulated glucagon secretion. Protein succination, reflecting reduced activity of fumarase, is observed in α cells from hyperglycemic Fh1βKO and β-V59M gain-of-function KATP channel mice, diabetic Goto-Kakizaki rats, and patients with type 2 diabetes. Succination is also observed in renal tubular cells and cardiomyocytes from hyperglycemic Fh1βKO mice, suggesting that the model can be extended to other SGLT-expressing cells and may explain part of the spectrum of diabetic complications.
Keywords: Fh1; diabetes; glucagon; sodium-glucose co-transport; succination.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.
Figures
References
- Adam J., Ramracheya R., Chibalina M.V., Ternette N., Hamilton A., Tarasov A.I., Zhang Q., Rebelato E., Rorsman N.J.G., Martin-Del-Rio R. Fumarate hydratase deletion in pancreatic beta cells leads to progressive diabetes. Cell Rep. 2017;20:3135–3148.
- Adam J., Yang M., Bauerschmidt C., Kitagawa M., O’Flaherty L., Maheswaran P., Özkan G., Sahgal N., Baban D., Kato K. A role for cytosolic fumarate hydratase in urea cycle metabolism and renal neoplasia. Cell Rep. 2013;3:1440–1448.
- Akhmedov D., Braun M., Mataki C., Park K.S., Pozzan T., Schoonjans K., Rorsman P., Wollheim C.B., Wiederkehr A. Mitochondrial matrix pH controls oxidative phosphorylation and metabolism-secretion coupling in INS-1E clonal beta cells. FASEB J. 2010;24:4613–4626.
- Azarias G., Perreten H., Lengacher S., Poburko D., Demaurex N., Magistretti P.J., Chatton J.Y. Glutamate transport decreases mitochondrial pH and modulates oxidative metabolism in astrocytes. J. Neurosci. 2011;31:3550–3559.
- Berg J., Hung Y.P., Yellen G. A genetically encoded fluorescent reporter of ATP: ADP ratio. Nat. Methods. 2009;6:161–166.
- Bernstein L.H., Everse J. Studies on the mechanism of the malate dehydrogenase reaction. J. Biol. Chem. 1978;253:8702–8707.
- Bertero E., Prates Roma L., Ameri P., Maack C. Cardiac effects of SGLT2 inhibitors: the sodium hypothesis. Cardiovasc. Res. 2018;114:12–18.
- Blatnik M., Frizzell N., Thorpe S.R., Baynes J.W. Inactivation of glyceraldehyde-3-phosphate dehydrogenase by fumarate in diabetes: formation of S-(2-succinyl)cysteine, a novel chemical modification of protein and possible biomarker of mitochondrial stress. Diabetes. 2008;57:41–49.
- Blodgett D.M., Nowosielska A., Afik S., Pechhold S., Cura A.J., Kennedy N.J., Kim S., Kucukural A., Davis R.J., Kent S.C. Novel observations from next-generation RNA sequencing of highly purified human adult and fetal islet cell subsets. Diabetes. 2015;64:3172–3181.
- Bonner C., Kerr-Conte J., Gmyr V., Queniat G., Moerman E., Thevenet J., Beaucamps C., Delalleau N., Popescu I., Malaisse W.J. Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion. Nat. Med. 2015;21:512–517.
- Brereton M.F., Iberl M., Shimomura K., Zhang Q., Adriaenssens A.E., Proks P., Spiliotis I.I., Dace W., Mattis K.K., Ramracheya R. Reversible changes in pancreatic islet structure and function produced by elevated blood glucose. Nat. Commun. 2014;5:4639.
- Brown D.A., Perry J.B., Allen M.E., Sabbah H.N., Stauffer B.L., Shaikh S.R., Cleland J.G., Colucci W.S., Butler J., Voors A.A. Expert consensus document: mitochondrial function as a therapeutic target in heart failure. Nat. Rev. Cardiol. 2016;14:238–250.
- Casey J.R., Grinstein S., Orlowski J. Sensors and regulators of intracellular pH. Nat. Rev. Mol. Cell Biol. 2010;11:50–61.
- Cryer P.E. Managing diabetes: lessons from type 1 diabetes mellitus. Diabet. Med. 1998;15(Suppl 4):S8–S12.
- Cryer P.E. Hypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes. Diabetologia. 2002;45:937–948.
- Cryer P.E. Glycemic goals in diabetes: trade-off between glycemic control and iatrogenic hypoglycemia. Diabetes. 2014;63:2188–2195.
- DiGruccio M.R., Mawla A.M., Donaldson C.J., Noguchi G.M., Vaughan J., Cowing-Zitron C., van der Meulen T., Huising M.O. Comprehensive alpha, beta and delta cell transcriptomes reveal that ghrelin selectively activates delta cells and promotes somatostatin release from pancreatic islets. Mol. Metab. 2016;5:449–458.
- Dor Y., Brown J., Martinez O.I., Melton D.A. Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation. Nature. 2004;429:41.
- Dunning B.E., Foley J.E., Ahren B. Alpha cell function in health and disease: influence of glucagon-like peptide-1. Diabetologia. 2005;48:1700–1713.
- Eberhard D., Lammert E. The role of the antioxidant protein DJ-1 in type 2 diabetes mellitus. In: Ariga H., Iguchi-Ariga S.M.M., editors. DJ-1/PARK7 Protein: Parkinson’s Disease, Cancer and Oxidative Stress-Induced Diseases. Springer; 2017. pp. 173–186.
- Ferrannini E. Sodium-glucose co-transporters and their inhibition: clinical physiology. Cell Metab. 2017;26:27–38.
- Forbes J.M. Mitochondria-power players in kidney function? Trends Endocrinol. Metab. 2016;27:441–442.
- Forbes J.M., Cooper M.E. Mechanisms of diabetic complications. Physiol. Rev. 2013;93:137–188.
- Frier B.M. The incidence and impact of hypoglycemia in type 1 and type 2 diabetes. International Diabetes Monitor. 2009;21:210–218.
- Frizzell N., Lima M., Baynes J.W. Succination of proteins in diabetes. Free Radic. Res. 2011;45:101–109.
- Girard C.A., Wunderlich F.T., Shimomura K., Collins S., Kaizik S., Proks P., Abdulkader F., Clark A., Ball V., Zubcevic L. Expression of an activating mutation in the gene encoding the K(ATP) channel subunit Kir6.2 in mouse pancreatic β cells recapitulates neonatal diabetes. J. Clin. Invest. 2009;119:80–90.
- Granhall C., Park H.B., Fakhrai-Rad H., Luthman H. High-resolution quantitative trait locus analysis reveals multiple diabetes susceptibility loci mapped to intervals<800 kb in the species-conserved Niddm1i of the GK rat. Genetics. 2006;174:1565–1572.
- Hamilton A., Zhang Q., Salehi A., Willems M., Knudsen J.G., Ringgaard A.K., Chapman C.E., Gonzalez-Alvarez A., Surdo N.C., Zaccolo M. Adrenaline stimulates glucagon secretion by Tpc2-dependent Ca2+ mobilization from acidic stores in pancreatic α-cells. Diabetes. 2018;67:1128–1139.
- Herrera P.L. Adult insulin- and glucagon-producing cells differentiate from two independent cell lineages. Development. 2000;127:2317–2322.
- Jain D., Jain R., Eberhard D., Eglinger J., Bugliani M., Piemonti L., Marchetti P., Lammert E. Age- and diet-dependent requirement of DJ-1 for glucose homeostasis in mice with implications for human type 2 diabetes. J. Mol. Cell Biol. 2012;4:221–230.
- Jamison R.A., Stark R., Dong J., Yonemitsu S., Zhang D., Shulman G.I., Kibbey R.G. Hyperglucagonemia precedes a decline in insulin secretion and causes hyperglycemia in chronically glucose-infused rats. Am. J. Physiol. Endocrinol. Metab. 2011;301:E1174–E1183.
- Lai J.C.K., Cooper A.J.L. Brain α-ketoglutarate dehydrogenase complex: kinetic properties, regional distribution, and effects of inhibitors. J. Neurochem. 1986;47:1376–1386.
- Lopaschuk G.D., Verma S. Empagliflozin's fuel hypothesis: not so soon. Cell Metab. 2016;24:200–202.
- Masereel B., Pochet L., Laeckmann D. An overview of inhibitors of Na(+)/H(+) exchanger. Eur. J. Med. Chem. 2003;38:547–554.
- Massey V. Studies on fumarase. II. The effects of inorganic anions on fumarase activity. Biochem. J. 1953;53:67–71.
- Nagai R., Brock J.W., Blatnik M., Baatz J.E., Bethard J., Walla M.D., Thorpe S.R., Baynes J.W., Frizzell N. Succination of protein thiols during adipocyte maturation: a biomarker of mitochondrial stress. J. Biol. Chem. 2007;282:34219–34228.
- Parker H.E., Adriaenssens A., Rogers G., Richards P., Koepsell H., Reimann F., Gribble F.M. Predominant role of active versus facilitative glucose transport for glucagon-like peptide-1 secretion. Diabetologia. 2012;55:2445–2455.
- Pollard P.J., Spencer-Dene B., Shukla D., Howarth K., Nye E., El-Bahrawy M., Deheragoda M., Joannou M., McDonald S., Martin A. Targeted inactivation of fh1 causes proliferative renal cyst development and activation of the hypoxia pathway. Cancer Cell. 2007;11:311–319.
- Pollard P.J., Wortham N.C., Tomlinson I.P. The TCA cycle and tumorigenesis: the examples of fumarate hydratase and succinate dehydrogenase. Ann. Med. 2003;35:632–639.
- R Development Core Team . R Foundation for Statistical Computing; 2016. R: A Language and Environment for Statistical Computing.
- Ramracheya R.D., McCulloch L.J., Clark A., Wiggins D., Johannessen H., Olsen M.K., Cai X., Zhao C.M., Chen D., Rorsman P. PYY-dependent restoration of impaired insulin and glucagon secretion in type 2 diabetes following Roux-En-Y gastric bypass surgery. Cell Rep. 2016;15:944–950.
- Rorsman P., Ramracheya R., Rorsman N.J., Zhang Q. ATP-regulated potassium channels and voltage-gated calcium channels in pancreatic alpha and beta cells: similar functions but reciprocal effects on secretion. Diabetologia. 2014;57:1749–1761.
- Skrivarhaug T., Bangstad H.J., Stene L.C., Sandvik L., Hanssen K.F., Joner G. Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway. Diabetologia. 2006;49:298–305.
- Spegel P., Ekholm E., Tuomi T., Groop L., Mulder H., Filipsson K. Metabolite profiling reveals normal metabolic control in carriers of mutations in the glucokinase gene (MODY2) Diabetes. 2013;62:653–661.
- Tarasov A.I., Semplici F., Ravier M.A., Bellomo E.A., Pullen T.J., Gilon P., Sekler I., Rizzuto R., Rutter G.A. The mitochondrial Ca2+ uniporter MCU is essential for glucose-induced ATP increases in pancreatic beta-cells. PLoS One. 2012;7:e39722.
- Ternette N., Yang M., Laroyia M., Kitagawa M., O’Flaherty L., Wolhulter K., Igarashi K., Saito K., Kato K., Fischer R. Inhibition of mitochondrial aconitase by succination in fumarate hydratase deficiency. Cell Rep. 2013;3:689–700.
- Trube G., Rorsman P., Ohno-Shosaku T. Opposite effects of tolbutamide and diazoxide on the ATP-dependent K+ channel in mouse pancreatic beta-cells. Pflugers Arch. 1986;407:493–499.
- Unger R.H., Orci L. Paracrinology of islets and the paracrinopathy of diabetes. Proc. Natl. Acad. Sci. U S A. 2010;107:16009–16012.
- Vieira E., Liu Y.J., Gylfe E. Involvement of alpha1 and beta-adrenoceptors in adrenaline stimulation of the glucagon-secreting mouse alpha-cell. Naunyn Schmiedebergs Arch. Pharmacol. 2004;369:179–183.
- Walker J.N., Ramracheya R., Zhang Q., Johnson P.R., Braun M., Rorsman P. Regulation of glucagon secretion by glucose: paracrine, intrinsic or both? Diabetes Obes. Metab. 2011;13(Suppl 1):95–105.
- Wanner C., Inzucchi S.E., Zinman B. Empagliflozin and progression of kidney disease in type 2 diabetes. N. Engl. J. Med. 2016;375:1801–1802.
- Willson V.J.C., Tipton K.F. The effect of pH on the allosteric behaviour of Ox-brain NAD+-dependent isocitrate dehydrogenase. Eur. J. Biochem. 1980;109:411–416.
- Wright E.M., Loo D.D., Hirayama B.A. Biology of human sodium glucose transporters. Physiol. Rev. 2011;91:733–794.
- Zhang Q., Ramracheya R., Lahmann C., Tarasov A., Bengtsson M., Braha O., Braun M., Brereton M., Collins S., Galvanovskis J. Role of KATP channels in glucose-regulated glucagon secretion and impaired counterregulation in type 2 diabetes. Cell Metab. 2013;18:871–882.
- Zinman B., Wanner C., Lachin J.M., Fitchett D., Bluhmki E., Hantel S., Mattheus M., Devins T., Johansen O.E., Woerle H.J. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N. Engl. J. Med. 2015;373:2117–2128.
Source: PubMed